PRISM BioLab Co.,LTD [206A.T]

TOKYO, May 14 (Pulse News Wire) – Prism Biolab Co., Ltd. (206A.T) reported non-consolidated results for Q2 FY2026 (ending September 2026).

Revenue was ¥250 million (+15.8% YoY). operating profit was ¥584 million.

Net profit was ¥603 million. Total assets stood at ¥2.6 billion with an equity ratio of 81.8%.

Financial results — FY2026/9 (consolidated)

MetricCurrentYoY
Revenue¥253M+15.8%
Operating profit¥-584Mn/a
Net profit¥-603Mn/a

Source: TDNet filing · Figures in millions of yen

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.